Resolve Therapeutics Lands $1,083,334 New Financing Round

  • Feed Type
  • Date
    4/26/2012
  • Company Name
    Resolve Therapeutics
  • Mailing Address
    5400 Carillon Point Kirkland, WA 98033
  • Company Description
    Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy.
  • Website
    http://www.resolvebio.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,083,334
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.